Made in Pharmako’s TGA-licensed facility adhering to strict GMP protocols, PlexoZome also offers increased stability and customised particle size with Dynamic Light Scattering (DLS) validation. The presence of PlexoZomes formulations is verified through Transmission Electron Microscopy (TEM) and Cryo-TEM imaging, the only way to view the liposome structure and their bilayer membrane structure. Liposomes are tiny complex structures surrounded by a lipid bilayer membrane and are not visible with a standard light microscope. This structure and characteristics provide genuine liposomes with special targeted delivery advantages that are scientifically verified.”īecause of PlexoZome, a specialised technology now exists to create technically advanced structured vesicles “Because of PlexoZome, a specialised technology now exists to create technically advanced structured vesicles. As both brands and consumers recognise this, in addition to consumers wanting more convenient solutions, they seek ingredients with enhanced bioavailability,” said Geroge Kokkinis, Technical Director at Pharmako Biotechnologies. “By nature, many supplement ingredients require high doses and have slow onsets of action.
PlexoZome is an advanced targeted delivery liposomal technology for liquid formulations uniquely developed and made on-site in its licensed facility for fully customisable and stable liposomal ingredients. Gencor and Pharmako Biotechnologies have announced the latest liposome tech with its scientifically proven PlexoZome technology.
0 kommentar(er)
